[HTML][HTML] High prevalence of genotypes associated with sulfadoxine/pyrimethamine resistance in the rural area of Fougamou, Gabon
FM Boukoumba, JB Lekana-Douki, PB Matsiegui… - Journal of Global …, 2021 - Elsevier
Objectives Pregnancy-associated malaria (PAM) is a complex form of malaria. To prevent
PAM, several African countries have adopted intermittent preventive treatment with …
PAM, several African countries have adopted intermittent preventive treatment with …
High prevalence of sulphadoxine–pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville …
F Koukouikila-Koussounda, D Bakoua, A Fesser… - Infection, Genetics and …, 2015 - Elsevier
Intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine (IPTp-
SP) has not been evaluated in the Republic of Congo since its implementation in 2006 and …
SP) has not been evaluated in the Republic of Congo since its implementation in 2006 and …
Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic …
Abstract Background Point mutations in Plasmodium falciparum dihydrofolate reductase
(Pfdhfr) and dihydropteroate synthase (Pfdhps) genes which confer resistance to …
(Pfdhfr) and dihydropteroate synthase (Pfdhps) genes which confer resistance to …
Plasmodium falciparum Genetic Diversity and Resistance Genotype Profile in Infected Placental Samples Collected After Delivery in Ouagadougou
H Sawadogo, I Soulama, A Zida, C Zongo… - Infection and Drug …, 2023 - Taylor & Francis
Purpose Intermittent preventive treatment with sulfadoxine-pyrimethamine is widely used for
the prevention of malaria in pregnant women in Africa. Known resistance cases of …
the prevention of malaria in pregnant women in Africa. Known resistance cases of …
Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for …
AK Mbonye, J Birungi, SK Yanow… - Antimicrobial Agents …, 2015 - Am Soc Microbiol
The aim of this study was to assess the prevalence of mutations in Plasmodium falciparum
dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes among …
dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes among …
Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant …
P Chauvin, S Menard, X Iriart… - Journal of …, 2015 - academic.oup.com
Objectives To determine, 6 years after the adoption of intermittent preventive treatment of
pregnant women with sulfadoxine/pyrimethamine (IPTp-SP) in Cameroon,(i) the …
pregnant women with sulfadoxine/pyrimethamine (IPTp-SP) in Cameroon,(i) the …
Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late …
E Ruizendaal, MC Tahita, RB Geskus, I Versteeg… - Malaria journal, 2017 - Springer
Background Pregnant women are a high-risk group for Plasmodium falciparum infections,
which may result in maternal anaemia and low birth weight newborns, among other adverse …
which may result in maternal anaemia and low birth weight newborns, among other adverse …
Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria …
Background Plasmodium falciparum dihydrofolate reductase (Pfdhfr) and dihydropteroate
synthetase (Pfdhps) mutations compromise the effectiveness of sulfadoxine-pyrimethamine …
synthetase (Pfdhps) mutations compromise the effectiveness of sulfadoxine-pyrimethamine …
The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest …
Intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine (IPTp-
SP) is used to prevent malaria and associated unfavorable maternal and foetal outcomes in …
SP) is used to prevent malaria and associated unfavorable maternal and foetal outcomes in …
Analysis of sulphadoxine–pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun …
KA Fagbemi, SA Adebusuyi, D Nderu… - Infection, Genetics and …, 2020 - Elsevier
Intermittent preventive treatment in pregnancy with sulphadoxine− pyrimethamine (IPTp-SP)
is one of the main strategies for protecting pregnant women, fetus, and their new-born …
is one of the main strategies for protecting pregnant women, fetus, and their new-born …